Curriculum Vitae

ASSOCIATE PROF. DR. PANG YONG KEK

Associate Professor
  • Department of Medicine
    Faculty of Medicine
  • ykpang
  • 0379494422

AREAS OF EXPERTISE

  • RESPIRATORY DISEASES
    Respiratory Medicine, Chest Physician,

ACADEMIC QUALIFICATION

  • MRCP(UK)(1998), (Lain-Lain)
    Royal College of Physicians of London, United Kingdom
  • MD(USM)(1993), (Medicine)
    Universiti Sains Malaysia (USM)

ADMINISTRATIVE DUTIES

  • Head of Unit
    01 Jan 2023 - 31 Dec 2024 (Faculty)
  • Deputy Head
    04 Nov 2020 - present (Faculty)
  • Chairman
    01 Jun 2016 - present (Department of Medicine, Faculty of Medicine)
  • Deputy Head
    01 Mar 2019 - present (Faculty)
  • President
    03 Dec 2021 - 02 Dec 2023 (National)
  • Head of Unit
    19 Jul 2021 - 31 Dec 2022 (Faculty)
  • Committee Member
    01 Oct 2020 - 30 Sep 2022 (National)
  • Member of the UM Health Task Force (Technology & Tools Task Force)
    17 Sep 2021 - 16 Sep 2022 (University Malaya)
  • Committee Members
    06 Jul 2017 - 05 Jul 2019 (Faculty)
  • Committee Members
    15 Nov 2016 - 14 Nov 2018 (University Malaya)
  • Head of Unit
    01 Aug 2016 - 31 Jul 2018 (Department)
  • Chairman
    01 Jun 2017 - 31 May 2018 (Faculty)
  • Committee Members
    15 Jan 2016 - 14 Jan 2018 (Department of Medicine, Faculty of Medicine)
  • Task Force Leader
    30 Jan 2012 - 31 May 2017 (Department of Medicine, Faculty of Medicine)
  • Chairman
    01 Jan 2015 - 31 Dec 2016 (National)
  • Chairman
    01 Jun 2015 - 31 May 2016 (Department of Medicine, Faculty of Medicine)
  • Task Force Member
    14 Jul 2014 - 13 Jul 2015 (Department of Medicine, Faculty of Medicine)
  • Coordinator
    13 Feb 2014 - 12 Feb 2015 (University Malaya)
  • Task Force Member
    01 Jan 2012 - 31 Dec 2013 (Department of Medicine, Faculty of Medicine)

MEMBERSHIPS

  • MALAYSIAN MEDICAL ASSOCIATION, ACTIVE MEMBER
    Since 1998 (National)
  • SPECIALIST IN NSR, MEMBER
    Since 2013 (National)
  • PRESIDENT OF THE SOCIETY, PRESIDENT/ CHIEF
    Since 2003 (National)
  • MEMBER OF THE ROYAL COLLEGES OF PHYSICIANS, MEMBER
    Since 1998 (International)
  • MEMBER OF THE BOARD OF TRUSTEES, BOARD OF DIRECTORS
    2017 to 2023 (National)
  • COUNCILLOR FOR MALAYSIA, COMMITTEE MEMBER
    2016 to 2022 (International)
  • EUROPEAN RESPIRATORY SOCIETY, MEMBER
    2016 to 2022 (International)
  • COUNCILLOR OF THE SOCIETY, COMMITTEE MEMBER
    2016 to 2022 (International)
  • LUNG FOUNDATION OF MALAYSIA, BOARD MEMBER
    2017 to 2021 (National)
  • ASIAN PACIFIC RESPIROLOGY SOCIETY, COUNCIL MEMBER
    2016 to 2020 (International)
  • MALAYSIAN THORACIC SOCIETY, PRESIDENT/ CHIEF
    Since 2017 (National)

AWARD AND STEWARDSHIP

  • Web of Science Incentive Payment_Article Number M2021.08.265.012202
    IPPP, 2023 (University)
  • Web of Science Incentive Payment_
    IPPP, 2023 (University)
  • Web of Science Payment_Article number M2022.06.2410.0620220137
    IPPP, 2022 (University)
  • Web of Science (WoS) Incentive Payment_Article Number_S2022.09.293.1232
    IPPP, 2022 (University)
  • Anugerah Aktiviti Berkumpulan Dan Khidmat Social
    University Malaya Medical Centre, 2022 (University)
  • WoS incentive for publications
    IPPP, 2021 (University)
  • Best Team Award_COVID-19 Task Force
    University Malaya Medical Centre, 2021 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2016 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2015 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2007 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2006 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2005 (University)

PUBLICATIONS

Article in Journal
WoS
  1. Piotrowska, Z.; Ahn, M-J.; Pang, Y. K.; How, S. H.; Kim, S-W.; Voon, P. J.; Cortinovis, D. L.; De Castro Carpeno, J.; Tiseo, M.; Rodriguez Abreu, D.; Ramalingam, S. S.; Li, J.; Servidio, L.; Sadow, S.; Hartmaier, R. J.; Cho, B. C. (2022). ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib, ANNALS OF ONCOLOGY. 33(7), S1420-S1421. doi:10.1016/j.annonc.2022.08.055
  2. Sam, I-Ching; Chong, Yoong Min; Abdullah, Azwani; Fu, Jolene Yin Ling; Hasan, M. Shahnaz; Jamaluddin, Fadhil Hadi; Kamarulzaman, Adeeba; Lim, Koo Koon; Nor, Mohd Afiq Mohd; Pang, Yong Kek; Ponnampalavanar, Sasheela; Shahib, Muhammad Fadzil; Omar, Sharifah Faridah Syed; Chan, Jonathan Chia Jui; Perera, David; Chan, Yoke Fun (2022). Changing predominant SARS-CoV-2 lineages drives successive COVID-19 waves in Malaysia, February 2020 to March 2021, JOURNAL OF MEDICAL VIROLOGY. . doi:10.1002/jmv.27441
  3. Agarwal, Dhiraj; Hanafi, Nik Sherina; Khoo, Ee Ming; Parker, Richard A.; Ghorpade, Deesha; Salvi, Sundeep; Abu Bakar, Ahmad Ihsan; Chinna, Karuthan; Das, Deepa; Habib, Monsur; Hussein, Norita; Isaac, Rita; Islam, Mohammad Shahidul; Khan, Mohsin Saeed; Liew, Su May; Pang, Yong Kek; Paul, Biswajit; Saha, Samir K.; Wong, Li Ping; Yusuf, Osman M.; Yusuf, Shahida O.; Juvekar, Sanjay; Pinnock, Hilary (2021). Predictors for detecting chronic respiratory diseases in community surveys: A pilot cross-sectional survey in four South and South East Asian low- and middle-income countries, JOURNAL OF GLOBAL HEALTH. 11. doi:10.7189/jogh.11.04065
  4. Agarwal, Dhiraj; Hanafi, Nik Sherina; Khoo, Ee Ming; Parker, Richard; Ghorpade, Deesha; Salvi, Sundeep; Yusuf, Osman M.; Khan, Mohsin S.; Yusuf, Shahida O.; Das, Deepa; Paul, Biswajit; Isaac, Rita; Islam, Mohammad Shahidul; Saha, Samir; Liew, Su May; Hussein, Norita; Abu Bakar, Ahmad Ihsan; Pang, Yong Kek; Chinna, Karuthan; Wong, Li Ping; Juvekar, Sanjay; Pinnock, Hilary (2021). Predictors for detecting chronic respiratory diseases in population surveys: a pilot study for RESPIRE 4CCORD study, EUROPEAN RESPIRATORY JOURNAL. 58. doi:10.1183/13993003.congress-2021.PA1733
  5. Chan, Soo Chin; Sekhon, Jaspreet Kaur; Engkasan, Julia Patrick; Nathan, Jayakayatri Jeevajothi; Mirza, Fatim Tahirah; Liew, Su May; Hussein, Norita; Suhaimi, Anwar; Hanafi, Nik Sherina; Pang, Yong Kek; Yatim, Saari Mohamad; Jackson, Tracy; Fernandes, Genevie; Habib, G. M. Monsur; Pinnock, Hilary; Khoo, Ee Ming (2021). Barriers and challenges of implementing pulmonary rehabilitation in Malaysia: Stakeholders' perspectives, JOURNAL OF GLOBAL HEALTH. 11. doi:10.7189/jogh.11.02003
  6. Cheong, Ai Theng; Lee, Ping Yein; Sazlina, Shariff Ghazali; Salim, Hani; Hussein, Norita; Ramli, Rizawati; Pinnock, Hilary; Liew, Su May; Hanafi, Nik Sherina; Abu Bakar, Ahmad Ihsan; Ahad, Azainorsuzila Mohd; Pang, Yong Kek; Chinna, Karuthan; Khoo, Ee Ming (2021). Meeting the challenges of asthma management guidelines in public primary care clinics in Malaysia: a qualitative study, EUROPEAN RESPIRATORY JOURNAL. 58. doi:10.1183/13993003.congress-2021.PA1002
  7. Chong, Y. M., Chan, Y. F., Jamaluddin, M. F. H., Hasan, M. S., Pang, Y. K., Ponnampalavanar, S., . . . Sam, I. C. (2021). Detection of respiratory viruses in adults with suspected COVID-19 in Kuala Lumpur, Malaysia. Journal of Clinical Virology, 145, 8. doi: 10.1016/j.jcv.2021.105000
  8. Ghazali, Sazlina Shariff; Lee, Ping Yein; Cheong, Ai Theng; Salim, Hani Syahida; Hussein, Norita; Pinnock, Hilary; Liew, Su May; Hanafi, Nik Sherina; Ng, Chiu-Wan; Ramli, Rizawati; Ahad, Azainorsuzila Mohd; Ho, Bee Kiau; Isa, Salbiah Mohamed; Parker, Richard; Stoddart, Andrew; Pang, Yong Kek; Chinna, Karuthan; Khoo, Ee Ming (2021). A pictorial asthma action plan to improve asthma control in Malaysian adults, EUROPEAN RESPIRATORY JOURNAL. 58. doi:10.1183/13993003.congress-2021.PA3719
  9. Hanafi, N. S., Agarwal, D., Chippagiri, S., Brakema, E. A., Pinnock, H., Sheikh, A., . . . Collaborators, R. (2021). Chronic respiratory disease surveys in adults in low- and middle-income countries: A systematic scoping review of methodological approaches and outcomes. Journal of global health, 11, 11. doi: 10.7189/jogh.11.04026
  10. Hanafi, Nik Sherina; Agarwal, Dhiraj; Chippagiri, Soumya; Brakema, Evelyn; Pinnock, Hilary; Khoo, Ee Ming; Sheikh, Aziz; Liew, Su-May; Ng, Chiu-Wan; Isaac, Rita; Chinna, Karuthan; Wong, Li Ping; Hussein, Norita; Abu Bakar, Ahmad Ihsan; Pang, Yong-Kek; Juvekar, Sanjay (2021). Chronic obstructive pulmonary disease (COPD) prevalence surveys in low- and middle-income countries (LMICs): A systematic scoping review of methodologies, EUROPEAN RESPIRATORY JOURNAL. 58. doi:10.1183/13993003.congress-2021.PA3516
  11. Hussein, Norita; Liew, Su May; Hanafi, Nik Sherina; Khoo, Ee Ming; Pinnock, Hilary; Pang, Yong Kek; Kassim, Asiah; Lee, Ping Yein; Sazlina, Shariff; Cheong, Ai Teng; Chinna, Karuthan; Ramli, Rizawati; Ishak, Izan; Ho, Bee Kiau; Isa, Salbiah Mohamad; Aman, Zuzana; Nordin, Asnita; Tan, Siow Foon; Harun, Harzana; Abu Abu Bakar, Ahmad Ihsan; Ahad, Azainorsuzila Mohd Mohd; Parker, Richard; Sheikh, Aziz (2021). Primary care management of asthma -findings from the Klang Asthma Cohort Study in Malaysia, EUROPEAN RESPIRATORY JOURNAL. 58. doi:10.1183/13993003.congress-2021.PA1000
  12. Hussein, Norita; Ramli, Rizawati; Ishak, Izan; Ho, Bee Kiau; Isa, Salbiah Mohamad; Aman, Zuzana; Nordin, Asnita; Tan, Siow Foon; Harun, Harzana; Liew, Su May; Hanafi, Nik Sherina; Abu Bakar, Ahmad Ihsan; Lee, Ping Yein; Cheong, Ai Theng; Ghazali, Sazlina Shariff; Ahad, Azainorsuzila Mohd; Pang, Yong Kek; Kassim, Asiah; Ng, Chiu-Wan; Chinna, Karuthan; Richard, Parker; Khoo, Ee Ming; Pinnock, Hilary; Sheikh, Aziz (2021). Assessment of asthma control and associated risk factors: findings from the Klang Asthma Cohort Study in Malaysia, EUROPEAN RESPIRATORY JOURNAL. 58. doi:10.1183/13993003.congress-2021.PA1001
  13. Lee, P. Y., Cheong, A. T., Ghazali, S. S., Salim, H., Wong, J., Hussein, N., . . . Khoo, E. M. (2021). Barriers to implementing asthma self-management in Malaysian primary care: qualitative study exploring the perspectives of healthcare professionals. Npj Primary Care Respiratory Medicine, 31(1), 8. doi: 10.1038/s41533-021-00250-y
  14. Liew, Su May; Khoo, Ee Ming; Pinnock, Hilary; Mccarthy, Sylvia; Lim, Zee Nee; Pang, Yong Kek; Hanafi, Nik Sherina; Hussein, Norita; Abu Bakar, Ahmad Ihsan; Chan, Yun Li; Sheikh, Aziz (2021). Exploring the provision of supportive care for people with severe, potentially life limiting chronic obstructive pulmonary disease in Malaysia: a qualitative study, EUROPEAN RESPIRATORY JOURNAL. 58. doi:10.1183/13993003.congress-2021.PA3552
  15. Pang, Y. K., Ismail, A. I., Chan, Y. K. F., Cheong, A., Chong, Y. M., Doshi, P., . . . Taurel, A. F. (2021). Influenza in Malaysian adult patients hospitalized with community-acquired pneumonia, acute exacerbation of chronic obstructive pulmonary disease or asthma: a multicenter, active surveillance study. Bmc Infectious Diseases, 21(1), 14. doi: 10.1186/s12879-021-06360-9
  16. Park, K., Janne, P. A., Kim, D. W., Han, J. Y., Wu, M. F., Lee, J. S., . . . Noh, Y. S. (2021). Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study. Cancer, 127(9), 1407-1416. doi: 10.1002/cncr.33385
  17. Chai, C. S., Liam, C. K., Poh, M. E., Ong, D. B. L., Pang, Y. K., Cheah, P. L., . . . Alip, A. (2020). Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors. Cancer Management and Research, 12, 5439-5450. doi: 10.2147/cmar.s253760
  18. Chai, C. S., Liam, C. K., Poh, M. E., Ong, D. B. L., Pang, Y. K., Cheah, P. L., . . . Alip, A. (2020). Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors. Cancer Management and Research, 12, 5439-5450. doi: 10.2147/cmar.s253760
  19. Chai, C. S., Mos, S. B., Ng, D. L. C., Goh, G., Su, A. T., Ibrahim, M. A. B., . . . Liam, C. K. (2020). Clinical phenotypes and heath-related quality of life of COPD patients in a rural setting in Malaysia - a cross-sectional study. Bmc Pulmonary Medicine, 20(1), 9. doi: 10.1186/s12890-020-01295-4
  20. Subakir, H., Chong, Y. M., Chan, Y. F., Hasan, M. S., Jamaluddin, M. F. H., Pang, Y. K., . . . Sam, I. C. (2020). Selective media and real-time PCR improves diagnosis of melioidosis in community-acquired pneumonia in a low-incidence setting in Kuala Lumpur, Malaysia. Journal of Medical Microbiology, 69(1), 49-51. doi: 10.1099/jmm.0.001108
  21. Chai, C. S., Liam, C. K., Pang, Y. K., Ng, D. L. C., Tan, S. B., Wong, T. S., Sia, J. E. (2019). Clinical phenotypes of COPD and health-related quality of life: a cross-sectional study. International Journal of Chronic Obstructive Pulmonary Disease, 14, 565-573. doi:10.2147/copd.s196109
  22. Gray, J. E., Okamoto, I., Sriuranpong, V., Vansteenkiste, J., Imamura, F., Lee, J. S., . . . Ramalingam, S. S. (2019). Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer. Clinical Cancer Research, 25(22), 6644-6652. doi:10.1158/1078-0432.ccr-19-1126
  23. Rajadurai, P., Cheah, P. L., How, S. H., Liam, C. K., Annuar, M. A. A., Omar, N., . . . Tho, L. M. (2019). Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Ontological Society. Lung Cancer, 136, 65-73. doi:10.1016/j.lungcan.2019.08.005
  24. Tan, S. B., Liam, C. K., Pang, Y. K., Ng, D. L. C., Wong, T. S., Khoo, K. W. S., . . . Chai, C. S. (2019). The Effect of 20-Minute Mindful Breathing on the Rapid Reduction of Dyspnea at Rest in Patients With Lung Diseases: A Randomized Controlled Trial. Journal of Pain and Symptom Management, 57(4), 802-808. doi:10.1016/j.jpainsymman.2019.01.009
Scopus
  1. Chong Y.M., Chan Y.F., Jamaluddin M.F.H., Hasan M.S., Pang Y.K., Ponnampalavanar S., Omar S.F.S., Sam I.-C. (2022). Rhinovirus/enterovirus was the most common respiratory virus detected in adults with severe acute respiratory infections pre-COVID-19 in Kuala Lumpur, Malaysia, PloS one. 17(9), e0273697. doi:10.1371/journal.pone.0273697
  2. How S.H., Liam C.K., Abidin M.A.Z., Hasbullah H.H., Tho L.M., Ho G.F., Nor I.M., Pang Y.K., Ho K.F., Thiagarajan M., Ariffin R., Samsudin A., Omar A., Tan S.N., Ong C.K., Soon S.Y., Poh M.E. (2022). Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia, Cancer Management and Research. 14, 1995-2005. doi:10.2147/CMAR.S364713
  3. How S.H., Tho L.M., Liam C.K., Hasbullah H.H., Ho G.F., Muhammad Nor I., Poh M.E., Ho K.F., Thiagarajan M., Samsudin A., Omar A., Ong C.K., Pang Y.K., Soon S.Y. (2022). Programmed death-ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non-small-cell lung cancer in a resource-limited country, Thoracic Cancer. 13(11), 1676-1683. doi:10.1111/1759-7714.14442
  4. Loh T.C., Pang Y.K., Liam C.K., Chew M.F., Tan J.L. (2022). Metastatic pulmonary calcification mimicking pulmonary tuberculosis: A case report, Respirology Case Reports. 10(10). doi:10.1002/rcr2.1030
  5. Sam I.-C., Chong Y.M., Abdullah A., Fu J.Y.L., Hasan M.S., Jamaluddin F.H., Kamarulzaman A., Lim K.K., Mohd Nor M.A., Pang Y.K., Ponnampalavanar S., Shahib M.F., Syed Omar S.F., Chan J.C.J., Perera D., Chan Y.F. (2022). Changing predominant SARS-CoV-2 lineages drives successive COVID-19 waves in Malaysia, February 2020 to March 2021, Journal of Medical Virology. 94(3), 1146-1153. doi:10.1002/jmv.27441
  6. Sazlina S.G., Lee P.Y., Cheong A.T., Hussein N., Pinnock H., Salim H., Liew S.M., Hanafi N.S., Abu Bakar A.I., Ng C.-W., Ramli R., Mohd Ahad A., Ho B.K., Mohamed Isa S., Parker R.A., Stoddart A., Pang Y.K., Chinna K., Sheikh A., Khoo E.M., Sazlina S.G., Khoo E.M., Pinnock H., Sheikh A. (2022). Feasibility of supported self-management with a pictorial action plan to improve asthma control, NPJ primary care respiratory medicine. 32(1), 34. doi:10.1038/s41533-022-00294-8
  7. Tan M.P., Leong C.L., Pang Y.K., Razali R.M., Ismail A.I., Sam I.-C., Abdul Rani R., Chong J., Mohd Zim M.A., Musa A.N., Leong J.H., Idris S., Khor J., Cheong A., El Guerche-Seblain C., Hasmukharay K., Arumugam M., Khalid K.E., Ismail I., Cheah W.K. (2022). Dearth of influenza among older adults admitted with respiratory symptoms in Malaysia during the coronavirus disease 2019 pandemic in 2021, Frontiers in Medicine. 9. doi:10.3389/fmed.2022.977614
  8. Wong C.K., Sia L.C., Min Ooi N.Z., Chan W.Y., Pang Y.-K. (2022). Severe COVID-19 with persistent respiratory failure A retrospective cohort study in a tertiary centre in Malaysia, PLoS ONE. 17(11 November). doi:10.1371/journal.pone.0276848
Others
  1. Sam, I. C., Chong, Y. M., Abdullah, A., Fu, J. Y. L., Shahnaz Hasan, M., Jamaluddin, F. H., ... & Chan, Y. F. (2021). Changing predominant SARS CoV 2 lineages drive successive COVID 19 waves in Malaysia, February 2020 to March 2021. Journal of Medical Virology.
  2. Haida Subakir , Yoong Min Chong , Yoke Fun Chan, M. Shahnaz Hasan, Mohamad Fadhil Hadi Jamaluddin , Yong Kek Pang, Sasheela Ponnampalavanar , Sharifah Faridah Syed Omar , I-Ching Sam. Selective media and real-time PCR improves diagnosis of melioidosis in community-acquired pneumonia in a low-incidence setting in Kuala Lumpur, Malaysia. Journal of Medical Microbiology. First published: 21 November 2019
  3. Jhanelle E. Gray, Isamu Okamoto, Virote Sriuranpong, Johan Vansteenkiste, Fumio Imamura, Jong Seok Lee, Yong-Kek Pang, Manuel Cobo, Kazuo Kasahara, Ying Cheng, Naoyuki Nogami, Eun Kyung Cho, Wu Chou Su, Guili Zhang, Xiangning Huang, Xiaocheng Li-Sucholeiki, Brian Lentrichia, Simon Dearden, Suzanne Jenkins, Matilde Saggese, Yuri Rukazenkov and Suresh S. Ramalingam. Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non Small Cell Lung Cancer. Clin Cancer Res November 15 2019 (25) (22) 6644-6652; DOI: 10.1158/1078-0432.CCR-19-1126
  4. Rajadurai P, Cheah PL, How SH, Liam CK, Annuar MAA, Omar N, Othman N, Marzuki NM, Pang YK, Bustamam RSA, Tho LM (2019). Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological Society. Lung Cancer 2019 Oct; 136:65-73
  5. Subakir H, Chong YM, Chan YF, Hasan MS, Jamaluddin MFH, Pang YK Ponnampalavanar3 S, Syed Omar SF, Sam IC. (2019). Selective media and real-time PCR improves diagnosis of melioidosis in community-acquired pneumonia in a low-incidence setting in Kuala Lumpur, Malaysia. Journal of Medical Microbiology. doi: 10.1099/jmm.0.001108.
  6. C S Chai S-B Tan D L C Ng C K Liam Y K Pang. A randomized controlled trial of mindfulness breathing exercise in patients with advanced lung cancer. Annals of Oncology, Volume 29, Issue suppl_9, 1 November 2018
  7. Ng, K. T., Oong, X. Y., Lim, S. H., Chook, J. B., Takebe, Y., Chan, Y. F., ... & Tee, K. K. (2018). Viral Load and Sequence Analysis Reveal the Symptom Severity, Diversity, and Transmission Clusters of Rhinovirus Infections. Clinical Infectious Diseases, ciy063.
  8. Xiang Yong Oong, Jack Bee Chook, Kim Tien Ng, Wei Zhen Chow, Kok Gan Chan, Yong Kek Pang, Yoke Fun Chan,, Adeeba Kamarulzaman and Kok Keng Tee. The role of human Metapneumovirus genetic diversity and nasopharyngeal viral load on symptom severity in adults. Virology Journal (2018) 15:91
  9. Yong-Kek Pang as Primary Expert Panel. Malaysian Guidelines for the Peri-operative Care of Adults with Obstructive Sleep Apnoea. Published by College of Anaesthesiologists, Academy of Medicine of Malaysia Malaysian Society of Anaesthesiologists
  10. Chai CS, Liam CK, Poh ME et al.(2017). Epidermal growth factor receptor mutation in newly diagnosed lung adenocarcinoma. J Respir Med Lung Dis; 2(2): 1016.
  11. Al-Khannaq MN, Ng KT, Oong XY, Pang YK, Takebe Y, Chook JB, Hanafi NS, Kamarulzaman A, Tee KK. 2016. Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia. Virol J 2016; 13(1):33.
  12. Al-Khannaq, M.N., Ng, K.T., Oong, X.Y., Pang, Y.K., Takebe, Y., Chook, J.B., Hanafi, N.S., Kamarulzaman, A. and Tee, K.K., 2016. Diversity and Evolutionary Histories of Human Coronaviruses NL63 and 229E Associated with Acute Upper Respiratory Tract Symptoms in Kuala Lumpur, Malaysia.The American journal of tropical medicine and hygiene, pp.15-0810.
  13. Chow WZ, Chan YF, Oong XY, Ng LJ, Nor E SS, Ng KT, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Genetic diversity, seasonality and transmission network of human metapneumovirus: identification of a unique sub-lineage of the fusion and attachment genes. Sci Rep 2016; 6:27730.
  14. Ng KT, Chook JB, Oong XY, Chan YF, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Performance of a Taqman assay for improved detection and quantification of human rhinovirus viral load. Sci Rep 2016; 6:34855.
  15. K. Hasmukharay, N. Saedon, Y.K. Pang, C.K. Liam, K.M. Tan. What did you do for a living? The importance of a Comprehensive Geriatric Assessment. European Geriatrics Medicine 6 (2015): 462 464. DOI: http://dx.doi.org/10.1016/j.eurger.2015.06.006
  16. Kim Tien Ng, Xiang Yong Oong, Yong Kek Pang, Nik Sherina Hanafi, Adeeba Kamarulzaman, Kok Keng Tee. Outbreaks of enterovirus D68 in Malaysia: genetic relatedness to the recent US outbreak strains. Emerging Microbes & Infections. 08/2015 4(8): e47. DOI: 10.1038/emi.2015.47
  17. Ng KT, Oong XY, Pang YK, Hanafi NS, Kamarulzaman A, Tee KK. Outbreaks of enterovirus D68 in Malaysia: genetic relatedness to the recent US outbreak strains. Emerging microbes & infections 2015;4(8), p.e47.
  18. Oong XY, Ng KT, Lam TTY, Pang YK, Chan KG, Hanafi NS, Kamarulzaman A, Tee KK. Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014. PloS ONE 2015;10(8), p.e0136254
  19. Hong Yien Tan, Yean Kong Yong, Sin How Lim, Sasheela Ponnampalavanar, Sharifah F. S. Omar, Yong Kek Pang, Adeeba Kamarulzaman, Patricia Price, Suzanne M. Crowe and Martyn A. French,. Tuberculosis (TB)- associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes. Sexual Health. http://dx.doi.org/10.1071/SH14093
  20. Liam CK, Leow HR, How SH, Pang YK, Chua KT, Lim BK, Lai NL, Kuan YC, Pailoor J, Rajadurai P. Epidermal growth factor receptor mutations in non- small cell lung cancers in a multiethnic malaysian patient population. Asian Pacific Journal of Cancer Prevention, Vol 15, 2014
  21. Liam CK, Pang YK, Poh ME. Letter to the editor: EGFR mutations in Asian patients with advanced lung adenocarcinoma. Journal of Thoracic Oncology 2014 Sep; 9(9):e70-71.
  22. Mau-Ern Poh, Chong-Kin Liam, Jiunn-Liang Tan, Yong- Kek Pang, Chee-Kuan Wong, Ken-Siong Kow. Acrometastasis from an epidermal-growth-factor- receptor (EGFR) mutation-positive lung adenocarcinoma. Cancer Treatment Communications (2014), http://dx.doi.org/10.1016/j.ctrc.2014.08.004
  23. Pang YK. Close contact investigation of TB in high- burden, low- and middle-income countries. Malays Fam Physician 2014;9(2):11-7
  24. Siew-Mooi Ching, Yong-Kek Pang, David Price, Ai- Theng Cheong, Ping-Yein Lee, Ismail Irmi, Hassan Faezah, Ismail Ruhaini, Yook-Chin Chia Detection of airflow limitation using a handheld spirometer in a primary care setting Respirology (2014) doi: 10.1111/resp.12291
  25. Tan, H. Y., Yong, Y. K., Lim, S. H., Ponnampalavanar, S., Omar, S. F., Pang, Y. K., ... & French, M. A. (2014). Tuberculosis (TB)-associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes. Sexual health, 11(6), 532-539.
  26. Chong-Kin Liam Yong-Kek Pang and Keong-Tiong Chua. Satisfaction level and asthma control among Malaysian asthma patients on Symbicort Maintenance and Reliever Therapy (SMART) in the primary care setting (SMARTEST study). Asian Pac J Allergy Immunol 2013;32: DOI 10.12932/AP0359.32.2.2013
  27. Journal Chong-Kin Liam, Yong-Kek Pang,Mau-Ern Poh,Ken- Siong Kow,Chee-Kuan Wong, Raymond Varughese. Advanced right lung adenocarcinoma with ipsilateral breast metastasis. Respirology. doi:10.1002/rcr2.14.
  28. Journal Mau-Ern Poh, Chong-Kin Liam, Yong-Kek Pang & Keong-Tiong Chua. Endobronchial metastasis from resected renal cell carcinoma causing total lung collapse. Respirology Case Reports. doi: 10.1002/rcr2.16
  29. Journal Yong-Kek Pang, Yun-Fong Ngeow, Yan-Ling Wong & Chong-Kin Liam. Mycobacterium abscessus to treat or not to treat? Respirology. doi: 10.1002/rcr2.17
  30. Ngeow YF, Leong ML, Wong YL, Wong GJ, Tan JL, Wee WY, Ong CS, Pang YK, Choo SW. 2013. Draft genome sequence of Mycobacterium massiliense strain M159, showing phenotypic resistance to B-lactam and tetracycline antibiotics. Genome Announc. 1(4):e00669-13. doi:10.1128/genomeA.00669-13
  31. Chong-Kin LIAM, Muventhiran RUTHRANESAN, Chee-Hong LEE, Yong-Kek PANG, Keong-Tiong CHUA and Boon-Khaw LIM. Outcomes of Malaysian patients with advanced lung adenocarcinoma and unknown epidermal growth factor receptor mutation status advanced lung adenocarcinoma treated with gefitinib. Asia Pac J Clin Oncol 2012
  32. Lee CH, Liam CK, Pang YK, Chua KT, Lim BK, Lai NL. Successful pregnancy with epidermal growth factor receptor tyrosine kinase inhibitor treatment of metastatic lung adenocarcinoma presenting with respiratory failure. Lung Cancer 2011; 74:349-51
  33. C E Lee, A A Zain, Y K Pang. Antiphospholipid Syndrome with Pulmonary Artery Embolism and Multiple Venous Thromboses. Med J Malaysia Vol 65 No 3 September 2010
  34. Chong-Kin Liam, Yong-Kek Pang, Shyamala Poosparajah and Keong-Tiong Chua (Guest Editorial) Community- Acquired Pneumonia: An Asia Pacific Perspective , Respirology (2007) 12, 162 164
  35. Chong-Kin Liam, Yong-Kek Pang, Shyamala Poosparajah, Keong-Tiong Chua Obstructed Breathing During Sleep And Obstructive Sleep Apnoea Syndrome Assessment And Treatment. CME for MJM 21 Feb 2007
  36. Liam CK, Pang YK, Shyamala P. Diagnostic yield of flexible bronchoscopic sampling procedures in lung cancer patients according to the cell type and tumour location. Singapore Medical Journal 2007; 48:625-631
  37. Chong-Kin Liam, Yong-Kek Pang And Chai-Hooi Leow, (Letter to Editor) Gefitinib Is An Additional Prognostic Factor In Metastatic Lung Adenocarcinoma Response , Respirology (2006) 11, 836
  38. Chong-Kin Liam, Yong-Kek Pang, Chai-Hooi Leow, Shyamala Poosparajah, Ashoka Menon. Changes In The Distribution Of Lung Cancer Cell Types And Patient Demography In A Developing Multiracial Asian Country: Experience Of A University Teaching Hospital. Lung cancer (2006) 53, 23 -30.
  39. Chong-Kin Liam, Yong-Kek Pang, Chai-Hooi Leow. Epidermal Growth Factor Receptor Targeted Therapy With Gefitinib In Locally Advanced And Metastatic Primary Lung Adenocarcinoma. Respirology (2006) 11, 287-291
  40. How SH, Azlin S, Pang YK, Liam CK. Case report: A Case Of Lymphangioleiomyomatosis With Multiple Angiomyolipomas In The Kidneys Journal of the University Malaya Medical Centre. JUMMEC 2006; 9(2)
  41. Liam CK, Pang Y-K, Poosparajah S. Pulmonary Tuberculosis Presenting As Community-Acquired Pneumonia , Respirology 2006; 11: 786 792
  42. Y K Pang, C K Liam, C H Leow, P Shyamala, A R Zal. Tracheobronchial Stenting Is Safe And Effective In Relieving Upper Airway Obstruction. MJM Vol 61 No 2 June 2006
Chapter in Books
  1. Yong-Kek Pang. Drugs and The Respiratory System. In Y.K. Chan, Kwee Peng Ng, Debra Si Mui Sim (Eds). Pharmacological Basis of Acute Care (pp 101-110). Springer International Publishing Switzerland 2015
Article in Proceeding
  1. OA 05.02 - Osimertinib vs SoC EGFR-TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA): Plasma ctDNA Analysis Presenting Author(s): Jhanelle Elaine Gray | Author(s): Isamu Okamoto, V. Sriuranpong, Johan F. Vansteenkiste, F. Imamura, J.S. Lee, Y. Pang, M. Cobo, K. Kasahara, R. Hodge, Brian B Lentrichia, S. Dearden, Suresh S Ramalingam
  2. Chai Chee Shee, Liam Chong Kin, Pang Yong Kek, Kow Keng Siong, Poh Mau Ern, Wong Chee Kuan, Tan Jiunn Liang. Gefitinib versus erlotinib as first-line treatment in EGFR mutant advanced lung adenocarcinoma. European Respiratory Journal 2016 48: OA3341
  3. Chai Chee Shee, Liam Chong Kin, Pang Yong Kek, Kow Keng Siong, Poh Mau Ern, Wong Chee Kuan, Tan Jiunn Liang. Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients. European Respiratory Journal 2016 48: PA4840; DOI: 10.1183/13993003.congress-2016.PA4840
  4. Sai-Hong Ou, Keunchil Park, Ji-Youn Han, Dong-Wan Kim, Lyudmila Bazhenova, Yong-Kek Pang, How Soon Hin, Oscar Juan, Jeewoong Son, Isabelle Voccia, Daniel Massey, Miyoung Kim and Pasi A. J nne. Abstract CT079: ELUXA 1: Ph II study of BI1482694 (HM61713) in patients (pts) with T790M-positive non-small cell lung (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI). Cancer Research 07/2016; 76(14 Supplement). DOI: 10.1158/1538-7445.AM2016-CT079 Published 15 July 2016

RESEARCH INTEREST

  • Tuberculosis
  • Sleep medicine

RESEARCH PROJECT

National
  1. 2022 - 2024, Government Agency - Manage by UMCARES
    Rebung 2.0: Smart Navigation Of The Early Cancer Diagnosis Care Pathway Extension Of Rebung Into Kg Cempaka & Seri Setia ( Co-Researcher)
  2. 2021 - 2022, Private Funding - Manage by UMCARES
    Cancer Multisectoral Collaboration Network In Implementing A Pilot Cancer Early Dectection Community Project To Reduce Breast And Other Cancers Early Diagnosis Barriers In The Urban B40 Group In Taman Medan Pj ( Co-Researcher)
  3. 2013 - 2015, Others MOHE
    Geran Sanjungan Penyelidikan-mo016-2013 ( Principal Investigator(PI))
  4. 2013 - 2015, Others MOHE
    Geran Sanjungan Penyelidikan Mo028-2013 ( Principal Investigator(PI))
  5. 2009 - 2011, Geran Penyelidikan Universiti Malaya (UMRG)
    THE PATHOGENESIS OF ADVERSE CONSEQUENCE OF THERAPY IN PATIENTS INFECTED WITH HIV AND MYCOBACTERIUM TUBERCULOSIS ( Principal Investigator(PI))
  6. 2021 - 2028, MERCK SHARP & DOHME (M) SDN. BHD.
    A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF MK-7684 WITH PEMBROLIZUMAB AS A CO-FORMULATION (MK-7684A) VERSUS PEMBROLIZUMAB MONOTHERAPY AS FIRST LINE TREATMENT FOR PARTICIPANTS WITH PD-L1 POSITIVE (TPS 1%) METASTATIC NON-SMALL CELL LUNG CANCER ( Principal Investigator(PI))
  7. 2021 - 2027, Merck Sharp & Dohme (M) Sdn. Bhd.
    A Phase III, Randomized, Double-blind Trial of Platinum Doublet Chemotherapy +/- Pembrolizumab (MK-3475) as Neoadjuvant/Adjuvant Therapy for Participants with Resectable Stage II, IIIA and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (NSCLC) (KEYNOTE-671) ( Principal Investigator(PI))
  8. 2020 - 2024, Yuhan Corporation
    A Phase III, Randomized, Double-blind Study to Assess the Efficacy and Safety of Lazertinib versus Gefitinib as the First-line Treatment in Patients with Epiderman Growth Factor Receptor Sensitizing Mutation Positive, Locally Advanced or Metatastic Non-Small Cell Lung Cancer. ( Principal Investigator(PI))
  9. 2021 - 2024, Incyte Corporation
    A Randomized, Double Blind, Phase 3 Study of Plati-num-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non-Small Cell Lung Cancer (PODI-UM-304) ( Co-Researcher)
  10. 2021 - 2023, Endeavor Biomedicines (Australia) Pty. Ltd
    A Phase 2, Multi-Center Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in subjects with Idiopathic Pulmonary Fibrosis (IPF) ( Principal Investigator(PI))
  11. 2018 - 2022, AstraZeneca AB (publ)
    A multicentre, open-label, single-arm, molecular profiling study of patients with EGFR mutation-positive locally advanced or metastatic NSCLC treated with osimertinib (ELIOS) ( Principal Investigator(PI))
  12. 2019 - 2022, Prestige BioPharma Pte. Ltd.
    A Randomized, Double-blind, Parallel Group, Equivalence, Multicenter Phase III Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin in patients with Metastatic or Recurrent Non-squamous Non-small Cell Lung Cancer ( Principal Investigator(PI))
  13. 2019 - 2022, Merck Sharp & Dohme (I.A) Corp.
    A Phase 3, randomized, double-blind trial of pembrolizumab (MK-3475) with or without lenvatinib (E7080/MK-7902) in participants with treatment-naive, metastatic non-small cell lung cancer (NSCLC) whose tumors have a tumor proportion score (TPS) greater than or equal to 1% (LEAP-007). ( Principal Investigator(PI))
  14. 2020 - 2021, Hospital Taping
    One-Year Surveillance Study Of Influenza and Respiratory Syncytial Virus Infections Among Hospitalised Older Adults (>=65 Years) in Malaysia ( Principal Investigator(PI))
  15. 2020 - 2021
    One-year hospital-based surveillance for influenza cases and Respiratory Syncytial Virus (RSV) in older adults ( 65 years) in Malaysia , Hospital Kuala Lumpur (HKL) ( Co-Researcher)
  16. 2012 - 2014, High Impact Research (HIR)
    Molecular Genetics of Respiratory Pathogens Associated with Respiratory Tract Infections (From January 2012) High Impact Research (HIR): Genetics of the Respiratory, Gastrointestinal, Central Nervous System and Blood-borne Pathogens ( Consultant)
Private
  1. 2017 - 2021, Merck Sharp & Dohme (M) Sdn. Bhd.
    A Phase 3, Randomized, Double-Blind Study of Pembrolizumab (MK-3475) plus Epacadostat (INCB024360) Versus Pembrolizumab plus Placebo as First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer Expressing High Levels of PD-L1. ( Principal Investigator(PI))
  2. 2017 - 2021, Novotech Clinical Research (M) Sdn. Bhd.
    A Two-Part, Open Label, Randomized, Phase II/III Study of Dinutuximab and Irinotecan versus Irinotecan for Second Line Treatment of Subjects with Relapsed or Refractory Small Cell Lung Cancer ( Principal Investigator(PI))
International
  1. 2022 - 2026, Novartis Corporation (Malaysia) Sdn Bhd
    KontRASt-02: A randomized, controlled, open label, phase III study evaluating the efficacy and safety of JDQ443 versus docetaxel in previously treated subjects with locally advanced or metastatic KRAS G12C mutant non-small cell lung cancer ( Principal Investigator(PI))
  2. 2022 - 2026, International Funding
    Nihr Global Health Research Unit On Respiratory Health (respire-2) ( Co-Researcher)
  3. 2021 - 2022, Insmed Incorporated
    A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib Administered Once Daily for 52 Weeks in Subjects with Non-Cystic Fibrosis Bronchiectasis The ASPEN Study ( Principal Investigator(PI))
  4. 2018 - 2021, mAbxience Research S.L.
    A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin in Combination with Carboplatin and Paclitaxel for the Treatment of Subjects with Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC) ( Principal Investigator(PI))
  5. 2008 - 2008, Pharmaceutical company (Pfizer)
    ZEPHYR study ( Consultant)

PAPER PRESENTED

INVITED SEMINAR
  1. TBNA - How I do it?, TBNA Workshop (National) (11 Apr 2014 - 11 Apr 2014)
INVITED SPEAKER
  1. Ethical Issues Faced in Digital Health Research, Interviews with Researchers, UMMC Medical Research Ethics Committee (University) (30 Nov 2022 - 30 Nov 2022)
  2. Management of Advanced Lung Cancer With Driver Mutations, UMMC Lung Cancer Workshop, UMMC Respiratory Unit (National) (29 Oct 2022 - 29 Oct 2022)
  3. How I Approach Chronic Dyspnoea, Malaysian thoracic Society Annual Congress 2022, Malaysian Thoracic Society (National) (13 Oct 2022 - 16 Oct 2022)
  4. Sequential vaccination strategies for adult pneumococcal disease, Malaysian Thoracic Society Annual Congress 2022, Malaysian Thoracic Society (National) (13 Oct 2022 - 16 Oct 2022)
  5. Lung Cancer: Be Lung Aware, Live Well, Breathe Well, Pink October Webinar, UMMC  (University) (08 Oct 2022 - 08 Oct 2022)
  6. Non-invasive Ventilation in COPD, The 2nd Indonesian Chronic Lung Disease International Meeting, Indonesian Society of Respirology (International) (24 Sep 2022 - 24 Sep 2022)
  7. Spirometry Essentials , POSH Focused Webinar Series: Fundamentals of Occupational Health Practices, POSH Academy and Consultancy Sdn Bhd (National) (10 Sep 2022 - 10 Sep 2022)
  8. Challenges and Opportunities to End TB in the COVID-19 era, College of Pathologists Annual Congress, College of Pathologists, Academy of Medicine, Malaysia (National) (22 Jun 2022 - 24 Jun 2022)
  9. Spirometry Results - What does it means?, Society of Occupational and Environmental Medicine Seminar Series, Society of Occupational and Environmental Medicine (National) (18 Jun 2022 - 18 Jun 2022)
  10. Breathe Without Fear, Traveller Essentials, Malaysian Infection Control and Infectious Diseases (National) (11 Jun 2022 - 11 Jun 2022)
  11. Informed Consent Processes, Good Clinical Practice Certification Course, UMMC Clinical Investigation Centre (University) (24 May 2022 - 26 May 2022)
  12. Addressing The Gaps In Asthma Care in Malaysia, World Asthma Day Launch, Asthma Malaysia (National) (19 May 2022 - 19 May 2022)
  13. Advances in EGFR TKI Strategies Among Asian Populations, Respiratory Update for Primary Care, UiTM (National) (26 Mar 2022 - 26 Mar 2022)
  14. When To Use Mono, Double and Triple Therapy in COPD, UiTM Respiratory Update for Primary Care, UiTM Faculty of Medicine (University) (26 Mar 2022 - 27 Mar 2022)
  15. Pneumococcal and Influenza Vaccines - Who & When, UiTM Respiratory Update for Primary Care, UiTM Faculty of Medicine (University) (26 Mar 2022 - 27 Mar 2022)
  16. Approach & Management of Tuberculosis, Masters of Family Medicine Lecture Series, Master of Family Medicine Coordinators (University) (24 Feb 2022 - 24 Feb 2022)
  17. Lung Cancer and COVID-19 - The Current Challenges, World Cancer Day Public Forum, University Malaya Medical Centre (University) (19 Feb 2022 - 19 Feb 2022)
  18. Overview of Asthma and COPD in the Asia Pacific Region, APSR 2015 Congress, Malaysian Thoracic Society & Asian Pacific Society of Respirology (International) (03 Dec 2015 - 06 Dec 2015)
  19. Deep Dive into INPULSIS Trials, IPF Advisory Board Meeting (National) (27 Nov 2015)
  20. The exclusion of lung disease in the diagnosis of PAH - a pulmonologist's perspective, PAH Masterclass, IJN & IPR (National) (21 Nov 2015)
  21. 1. Optimising care in patients with PE; 2. Role of NOACs in VTE Management_AMPLIFY & AMPLIFY EXT , Penang SPAF Workshop (National) (25 Oct 2015)
  22. Epidemiology and Management of Severe Allergic Asthma in Malaysia, Severe Allergic Asthma Expert Forum & Advisory Board Meeting (National) (12 Sep 2015)
  23. Current challenges in the treatment of pneumonia Infections, Columbia Asia ID Workshop (Others) (06 Sep 2015)
  24. Management of COPD , Respiratory CME (07 Jul 2015)
  25. Management and Update of Asthma in Primary care, Primary Care CME, Primary care department (Others) (23 Jun 2015)
  26. Targeting the small airways to control symptoms - final piece of the jigsaw puzzle, Respiratory Update, UiTM Medical Department (National) (06 Jun 2015)
  27. NOACs for DVT & PE, NOAC Workshop, UMMC (Others) (30 May 2015)
  28. Principles of Spirometry and Spirometric Values, Phase 1 - Basic Lung Function Workshop, Malaysian Thoracic Society (National) (23 May 2015)
  29. TB and infection control in the hospital , World Hand Hygiene Day 2015, Infectious Control Unit (Others) (14 May 2015)
  30. Omalizumab in Asthma, Respiratory CME seminar, UKM Respiratory Medicine Division (Others) (12 May 2015)
  31. Role of Spirometry in the management of COPD, 2nd International Asthma & Chest Diseases Conference , Chest and Heart Association of Bangladesh & Asthma Association Bangladesh (International) (05 May 2015)
  32. Targeted therapy in IPF INPULSIS Data, Respiratory Forum, Boehringer Ingelheim (National) (25 Apr 2015 - 26 Apr 2015)
  33. Spirometry in the Diagnosis and monitoring of COPD, JKN TwynControl CaRe Workshop, Academy of Medicine (National) (04 Apr 2015)
  34. Study Protocol & Investigator Brochure, GCP Workshop, Clinical Investigation Centre (University) (17 Mar 2015)
  35. 1. Management of tuberculosis; 2. Management of pneumonia, Intensive Care Nursing Course, School of Nursing (Others) (24 Jan 2015)
  36. Respiratory Tract infections_A Clinician Perspective, 15th Asian Pacific Congress on Clinical Microbiology and Infection (28 Nov 2014 - 28 Nov 2014)
  37. New Insights in CTEPH Management, PAH Masterclass 2014 (National) (22 Nov 2014 - 22 Nov 2014)
  38. 1. Asthma Maintenance Treatment 2. Asthma Attack Management at the Clinic , MACE Symposium (National) (28 Sep 2014 - 28 Sep 2014)
  39. Rationale of Quadrivalent Influenza Vaccine, Influenza Symposium (National) (16 Aug 2014 - 16 Aug 2014)
  40. An Overview of Chronic Pulmonary Diseases, Pulmonary Rehabilitation Workshop (University) (16 Aug 2014 - 16 Aug 2014)
  41. Clinical Trial Protocol & Investigator Brochure, Good Clinical Practice Workshop (University) (12 Aug 2014 - 12 Aug 2014)
  42. From SMART to SMARTEST in Asthma Treatment , Sibu Symposium (National) (10 Aug 2014 - 10 Aug 2014)
  43. Role of Pulmonologist in Diagnosis and Staging of Lung Cancer, Johor Oncology Meeting 2014  (National) (22 Jun 2014 - 22 Jun 2014)
  44. Sleep Apnoea Among End-stage Renal Disease Patients, Malaysian Nephrology Society Congress 2014 (National) (21 Jun 2014 - 21 Jun 2014)
  45. Screening and Surveillance of Latent TB for Healthcare Workers, MTS Annual Congress, Malaysian Thoracic Society (National) (15 Jun 2014 - 15 Jun 2014)
  46. 1. Lung cancer in Malaysia_An overview; 2. Molecular Signature of Accurate Classification of NSCLC , Penang Lung Cancer Symposium (National) (03 May 2014 - 03 May 2014)
  47. PCV vaccination in adults, Healthcare Alliance Awareness Workshop (National) (26 Apr 2014 - 26 Apr 2014)
  48. PAH - Is it a truly rare disease?, PAH Symposium (National) (23 Apr 2014 - 23 Apr 2014)
  49. 1.Lung cancer diagnosis; 2.Debate_DOTS versus Self-administered therapy, National Tb & Lung Diseases Conference (National) (29 Mar 2014 - 29 Mar 2014)
  50. 1. Respiratory Emergencies 2. Management of COPD Exacerbations, 3rd Penang Conference on Clinical Emergencies, Malaysian Medical Association (Penang Branch) (National) (08 Mar 2014 - 08 Mar 2014)
KEYNOTE SPEAKER
  1. Broadening Horizons - The Future of eHealth, Online Malaysian Medical Summit 2022, Malaysian Medics International (National) (30 Jul 2022 - 30 Jul 2022)
  2. Telemedicine, Research Methodology Workshop (RMW) 2022, Asian Medical Students Association (National) (06 May 2022 - 07 May 2022)
OTHERS
  1. NIV - Basic to Advanced Modes, MTS NIV Workshop (National) (29 Nov 2014 - 30 Nov 2014)
  2. Restrictive Lung Diseases, Lung Function Tests Certification Course, MTS (National) (01 Nov 2014 - 02 Nov 2014)
  3. Principles of Spirometry and Spirometric Values, Basic Lung Function Tests Certification Course_Phase 1 (National) (17 May 2014 - 19 May 2014)

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2023) External Reviewer for Research Project Submitted to Medical Research Ethics Committee, University, (External Evaluator)
  2. (2022) Examiner for The Respiratory Exit Viva Subpecialty Examination, National, (External Examiner)
  3. (2022) Examiner for The Master of Medicine Conjoint Board Examination, University, (External Examiner)
  4. (2022) Reviewer of Research Grant Application, University, (Reviewer)
  5. (2021) Rheumatoid Arthritis-Interstitial Lung Disease in a Rheumatology Centre in Malaysia: Prevalence and Associated Factors, National, (External Examiner)
  6. (2021) Respiratory Exit Viva Examination - Feb 2021, National, (External Examiner)
Contribution to event
  1. (2022) Guest Speaker On The Next Epoch: a Multidisciplinary Approach, University, (Panelist/Moderator)
  2. (2021) Lecture - Telemedicine in Copd, National, (Panelist/Moderator)
  3. (2021) Chairing & Lecture - Respiratory Vaccinations Update in Malaysia, National, (Panelist/Moderator)
  4. (2021) Lecture - Management of Covid-19 in Adult Patients, National, (Panelist/Moderator)
  5. (2021) Lecture - Overcoming Exacerbation Symptoms With Exercise from The Medical Perspective, National, (Panelist/Moderator)
  6. (2021) Keynote Lecture - Copd Year in Review: Best of 2021, National, (Panelist/Moderator)
  7. (2021) Lecture - Wheezing in Non-Asthmatic Adults, National, (Panelist/Moderator)
  8. (2021) Lecture - The Impact of Covid-19 On Lung Cancer Care, International, (Panelist/Moderator)
  9. (2021) Lecture_copd - The Era of Personalised Medicine, National, (Panelist/Moderator)
  10. (2021) Lecture - Spirometry Simplified Demystifying Its Complexity, National, (Panelist/Moderator)
  11. (2021) Lecture - Pharmacology of Antimicrobials Used in Ntm-Pd Treatment, National, (Panelist/Moderator)
  12. (2021) Lecture - Emr and Registries, University, (Panelist/Moderator)
  13. (2021) Lecture - Informed Consent for Trial Subjects, University, (Panelist/Moderator)

SUPERVISION

Postgraduate Student
Master
  1. (2024) A Feasibility Study of an Exercise Programme for Post Covid-19 Patients, ANMOL KAUR MANJIT SINGH
  2. (2020) Respiratory Medicine Fellowship Programme, Vijayan Munusamy (University Malaya Medical Centre (Ummc) (Pusat Perubatan Universiti Malaya)(Ppum))
  3. (2020) Pulse Dosage Tuning with a 2nd Generation EGFR-TKI that Exploits Adaptive Therapy to Eradicate Resistant Cancer Cells: A Translational Study with Promising Clinical Application in the Treatment of Non-Small Cell Lung Cancer, Amir Imran bin Faisal Hamdi (Universiti Putra Malaysia (UPM))
  4. (2019) Respiratory Medicine Fellowship Programme, Loh Thian Chee (University Malaya Medical Centre (Ummc) (Pusat Perubatan Universiti Malaya)(Ppum))
  5. (2017) A Retrospective Study to Evaluate The Prevalence, Aetiologies and Types of Interstitial Lung Disease at University Malaya Medical Centre from 2010 to 2020, Sia Leng Cheng (University Malaya Medical Centre (Ummc) (Pusat Perubatan Universiti Malaya)(Ppum))
Under Graduate Students
  1. (2022) Respiratory Subspecialty Training Programme
  2. (2021) , Loh Thian Chee
  3. (2015) Final Year Project, Wong Chee Kuan

SOCIAL RESPONSIBILITY ACTIVITIES

  • Donation Campaign for Oxygen Concentrators to Maeps and Other Hospitals During Covid-19, (14 May 2021 - 31 Aug 2021) (National)
  • As a Speaker to The Media and Launching The Campaign "You Are Best Shot”, (28 Apr 2021 - 28 Apr 2021) (National)
  • Scientific Chair for Apsr 2015 Congress, (03 Dec 2015 - 06 Dec 2015)
  • Organising Committee of Basic Lung Function Test Certification Course, (23 May 2015 - 24 May 2015)
  • Organising Committee and Speaker for Mts Non-Invasive Ventilation Workshop 2014, (29 Nov 2014 - 30 Nov 2014)
  • Scientific Chairman for Asian Pacific Lung Cancer Conference 2014, (06 Nov 2014 - 08 Nov 2014)
  • Organising Committee and Trainer for Lung Function Certification Course 2014, (01 Nov 2014 - 02 Nov 2014)
  • Organising Committee for Mts 2014 Annual Congress, (12 Jun 2014 - 15 Jun 2014)
  • Organising Committee for Mts 2013 Annual Congress, (14 Jun 2013 - 16 Jun 2013)
  • Organising Committee Member of Mts 2012 Annual Scientific Congress, (06 Jul 2012 - 08 Jul 2012)
  • 3rd Malaysian Tb Cpg Development Group Member (Still in Process), (29 Jul 2011 - 26 Dec 2012)
  • Scientific Chairman for 2011 Malaysian Thoracic Society Annual Congress, (22 Jul 2011 - 24 Jul 2011)
  • Vice President of Malaysian Thoracic Society, (24 Jul 2009 - 31 Jul 2017)
  • Organising Chairman for 11th Malaysian Thoracic Society Annual Congress, (24 Jul 2009 - 26 Jul 2009)
  • 2nd Malaysian Copd Cpg Development Group Member, (02 Jan 2009 - 20 Nov 2009)